|
Match
|
Document |
Document Title |
|
|
7618951 |
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes
The invention relates to the use of prebiotics for the preparation of food or pharmaceutical compositions which are intended for the treatment and/or prevention of hyperglycaemic syndromes and, in...
|
|
|
7601364 |
Carbohydrate mixtures
A carbohydrate mixture for dietetic foods and pharmaceuticals containing several carbohydrates is provided. The carbohydrate mixture comprises two different, substantially soluble carbohydrate...
|
|
|
7601347 |
Methods and compositions for controlled release of bioactive compounds
A controlled release pharmaceutical dosage form for bacteriophage is presented. The dosage form is prepared by drying the active ingredient together with a dispersion or solution of...
|
|
|
7566463 |
Oral rehydration compositions
An oral rehydration mixture (ORM) may include from 47 to 75 wt % of a glucose containing saccharide, from 6 to 13 wt % sodium chloride, from 6.5 to 19 wt % potassium chloride, from 2 to 5 wt %...
|
|
|
7563762 |
Composition and process for stabilizing of biomolecules
The present invention relates in general to the field of biotechnology. The invention particularly relates to a composition and process for stabilizing or preserving biological molecules, as well...
|
|
|
7563460 |
Enteric coated oral pharmaceutical to erode kidney stones
A treatment protocol by which a renal stone patient is administered a chelating agent, generally once a day and preferably by mouth, during a treatment phase and is later administered the same...
|
|
|
7560443 |
Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index
Mixtures of fructose and lactose are useful for reducing caloric intake and glycemic index for individuals who are overweight, glucose-impaired, diabetic, or who just consume too large a fraction...
|
|
|
7553981 |
Natural semi-synthetic and synthetic lipid derivatives of ceramide and sphingosine groups, drugs and the medical use thereof in the form of therapeutic agents in particular for dermatology
The subject of the present invention is new substances which are derived from naturally occurring ceramides and sphingosine and also from synthetic compounds with principally the same structure in...
|
|
|
7528113 |
Method and composition for the treatment of adenoviral ocular infections
Adenoviral infections and in particular ocular adenoviral infections, e.g. keratoconjunctivitis, can be treated or alleviated by the administration of a substance, interfering with the interaction...
|
|
|
7517980 |
Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from Pseudomonas
Compositions and methods are provided related to Pseudomonas bacteria. The compositions and methods may be used for diagnosis and therapy of medical conditions involving infection with ...
|
|
|
7504384 |
Use of lipid conjugates in the treatment of infection
This invention provides compounds and methods of use thereof in suppressing, inhibiting, preventing, or treating a pathogenic effect on a cell, including, inter alia, infection with intracellular...
|
|
|
7498317 |
Antibacterial agents and process for producing the same
An antibacterial agent showing a high affinity for Helicobactor pyroli and having an antibacterial effect specific to H. Pyroli. The agent has a chemical structure wherein an antibacterial...
|
|
|
7491707 |
Synthetic lipid-a-analogs and uses thereof
New synthetic Lipid-A analogs based on monosaccharide (1) and disaccharide (2) derivatives were designed and prepared in the present invention. Both structures (1) and (2) incorporate novel lipid...
|
|
|
7449448 |
Composition and uses therefor for combating hangovers
The present invention relates generally to a composition for use in the prophylaxis and/or treatment of one or more symptoms caused or exacerbated by consumption of alcohol which composition...
|
|
|
7414037 |
Hydrazide-containing CFTR inhibitor compounds and uses thereof
The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for the study and...
|
|
|
7402575 |
Methods of treating inflammation
Methods and compositions for treating myocardial dysfunction or inflammation are described. The methods of the invention involve administering an agent that can inhibit lysozyme to an animal in...
|
|
|
7390793 |
Micelles
The present invention provides micelles, solutions comprising micelles, methods for preparing micelles, and methods for delivering micelles to patients. The micelles have fixed, preselected...
|
|
|
7348316 |
Use of an anti-endotoxin drug in the prevention and treatment of disease
The invention provides methods for preventing and treating disease involving the use of an anti-endotoxin drug.
|
|
|
7332480 |
Compositions for the regulation of cytokine activity
Substances comprising carboxylated and/or sulfated oligosaccharides in substantially purified form, including compositions containing same and methods of using same, are disclosed for the...
|
|
|
7332184 |
Colonic cleansing composition and method
A colonic cleansing kit comprises an osmotic colonic evacuant, and an oral rehydration mixture. The oral rehydration mixture comprises sugar, and salt. The sugar comprises a glucose containing...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7276485 |
Flowable nondigestible oil and process for making
A flowable nondigestible oil composition having a Consistency in a temperature range of 20° C. to 40° C. of less than about 600 P.sec (n-1) . The flowable nondigestible oil contains a liquid...
|
|
|
7262178 |
Treatment of sepsis and septic shock
A method and composition for the treatment of humans or animals for septic shock and sepsis using a mixture of sophorolipids.
|
|
|
RE39789 |
Tumor therapy
Neoplasia is treated by administering to a mammalian host a composition comprising ligands for the NKG2D receptor. In addition, other NKG2D ligands, proteins specific for the neoplastic cells and...
|
|
|
7256171 |
Use of core 2 G1cNAc transferase inhibitors in treating inflammation
This invention provides compounds and methods for treating inflammation. The compounds modulate the core 2 oligosaccharide-mediated binding of inflammatory cells, such as neutrophils, to...
|
|
|
7226914 |
Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections
A method for treating and preventing various infections, including papilloma virus and fungal and parasitic infections is provided. In particular, an effective amount of a sulphated polysaccharide,...
|
|
|
7214667 |
Drugs against articular failure
The object of the present invention is to provide a composition which exerts a higher effect on recovering health from articular disorders than that attained by amino sugars and glycosaminoglycans....
|
|
|
7208479 |
Peritoneal dialysis solution containing modified icodextrins
The present invention provides a peritoneal dialysis solution that contains heat stable osmotic agents such as D-glucitols, gluconic acids and alkylglycosides produced the reduction, oxidation or...
|
|
|
7196072 |
High molecular weight polysaccharide fraction from Aloe vera with immunostimulatory activity
A complex, water soluble polysaccharide fraction having potent immunostimulatory activity isolated from Aloe vera . The polysaccharide fraction has an apparent molecular weight above 2 million...
|
|
|
7192937 |
Oligosaccharide-containing compositions and uses thereof
The use of compositions containing one or more oligosaccharides in an amount effective to disinfect and/or preserve medical devices, pharmaceutical preparations, and the like is described. Buffered...
|
|
|
7192914 |
Prevention of atherosclerosis and undesired blood clotting by reducing von Willebrand factor
This invention provides methods and compositions for treating and preventing atherosclerosis other undesired blood clotting. The methods for treating and preventing atherosclerosis and related...
|
|
|
7183265 |
Powdery product comprising crystalline β-maltose monohydrate, its preparation, and uses
The object of the present invention is to provide a powdery product comprising crystalline β-maltose monohydrate which is powderized by spray method, and has a high-solubility in aqueous solvents...
|
|
|
7182884 |
Bio-liquid crystal polymer and shaped material using same
A bio-liquid crystal polymer is made from a tissue-derived compound or the derivatives. The bio-liquid crystal polymer has a characteristic of liquid crystal under predetermined conditions and is...
|
|
|
7169606 |
Lyophilization of human platelets
A protectant mixture for use in preserving biological materials comprising at least one polyhydroxy compound, and phosphate ions; a preservation medium comprising a biological material, at least...
|
|
|
7157444 |
Aminosalicylate derivatives for treatment of inflammatory bowel disease
Therapeutic 5-aminosalicylic acid derivative compositions having general formula (I), wherein R is a 1-deoxy sugar residue or a poly(ethylene glycol) chain-containing residue, are provided. The...
|
|
|
7157431 |
Compositions of plant carbohydrates as dietary supplements
Compositions of plant carbohydrates for dietary supplements and nutritional support for promotion and maintenance of good health. Defined nutritionally effective amounts of one to eleven essential...
|
|
|
7157078 |
Devices and methods for eliminating termite colonies
This invention relates to devices, kits, and methods for eliminating termite colonies. The kits, devices, and methods employ a termiticidal bait matrix containing
a) a termiticide selected...
|
|
|
7153877 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7141542 |
Method for stabilizing biomolecules in liquid formulations
The invention is directed to a stable formulation of a biologically active protein useful for aerosol delivery to the respiratory tract of a patient in need of treatment comprising:
(a) a...
|
|
|
7132415 |
Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
The present invention provides therapeutic combinations and methods including at least one sterol or 5α-stanol absorption inhibitor that can be useful for treating xanthomas.
|
|
|
7119110 |
Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and...
|
|
|
7109189 |
Mitochondrially targeted antioxidants
The invention provides mitochondrially targeted antioxidant compounds comprising a lipophilic cation moiety covalently coupled to a glutathione peroxidase mimetic. These compounds can be used to...
|
|
|
7101859 |
Use of lipid conjugates in the treatment of diseases
The invention provides novel methods for treating disease based upon the medicinal use of lipids and phospholipids covalently bound to physiologically acceptable monomers or polymers....
|
|
|
7084131 |
Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition
A method for preparing a polydispersed saccharide composition in which a fructan-containing material is dissolved in water prior to partial enzymatic treatment of the fructans.
|
|
|
7084129 |
Antimicrobial quaternary surfactants based upon alkyl polyglycoside
The invention relates to a series of polyglycoside derivatives that contain water-soluble cationic groups introduced into the molecule by reaction with the hydroxyl groups present in the starting...
|
|
|
7081509 |
Method for producing highly functional, hyper branched polyester by means of enzymatic esterification
The present invention relates to a process for preparing highly functional hyperbranched polyesters which comprises reacting a reaction solution comprising solvent and
(a) one or more dicarboxylic...
|
|
|
7081448 |
Benzyllactobionamides as inhibitors of smooth muscle cell proliferation
This invention provides smooth muscle cell proliferation inhibitors of formula I having the structure
wherein
R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , and R 8 are each, independently,...
|
|
|
7071233 |
Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases
An improved medical treatment and medicine is provided to quickly and safely resolve HIV and other microbial infections. The inexpensive medicine can be self administered and maintained for the...
|
|
|
7056900 |
Disaccharide derivatives for treating hyperglycaemia
The invention relates to the use of the disaccharide derivatives 3′-aminosucrose, sucrose-C6-acid and palatinose-C6′-acid and/or of an amide or alkyl ester thereof for the prevention or...
|
|
|
7056899 |
Disaccharide derivatives for treating hyperglycaemia
The invention relates to the use of the disaccharide derivatives 3′-aminosucrose, sucrose-C6-acid and palatinose-C6′-acid and/or of an amide or alkyl ester thereof for the prevention or...
|